Literature DB >> 11954014

Patients' perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: a comparison with Wegener's granulomatosis.

Maarten M Boomsma1, Marc Bijl, Coen A Stegeman, Cees G M Kallenberg, Gary S Hoffman, Jan Willem Cohen Tervaert.   

Abstract

OBJECTIVE: To describe the patients' perceptions of the effects of systemic lupus erythematosus (SLE) and Wegener's granulomatosis (WG) on health, function, income, and interpersonal relationships.
METHODS: 114 patients with SLE, and 79 patients with WG completed a self-administered questionnaire. Patients had been diagnosed with SLE or WG for a median period of 10 and 5 years, respectively.
RESULTS: All patients experienced substantial functional morbidity. Two-thirds of the patients with SLE or WG reported either a periodic or permanent inability to perform daily activities at home and/or at work. Furthermore, SLE as well as WG had a considerable impact upon the psychological and social life, affecting their happiness and altering relationships.
CONCLUSION: Our study demonstrates that SLE and WG are associated with substantial medical morbidity resulting in physical and occupational disability. SLE has a profound impact on patients' lives, similar to that experienced in patients with WG.

Entities:  

Mesh:

Year:  2002        PMID: 11954014     DOI: 10.1002/art.10341

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  29 in total

1.  Psychological Factors that Link Socioeconomic Status to Depression/Anxiety in Patients with Systemic Lupus Erythematosus.

Authors:  Desiree R Azizoddin; Geraldine Zamora-Racaza; Sarah R Ormseth; Lekeisha A Sumner; Chelsie Cost; Julia R Ayeroff; Michael H Weisman; Perry M Nicassio
Journal:  J Clin Psychol Med Settings       Date:  2017-12

Review 2.  Development of comprehensive disease assessment in systemic vasculitis.

Authors:  Oliver Flossmann; Paul Bacon; Kirsten de Groot; David Jayne; Niels Rasmussen; Philip Seo; Kerstin Westman; Raashid Luqmani
Journal:  Ann Rheum Dis       Date:  2006-05-25       Impact factor: 19.103

3.  The effect of medication-related support on the quality of life of patients with vasculitis in relapse and remission.

Authors:  Delesha M Carpenter; Jessica A Kadis; Robert F Devellis; Susan L Hogan; Joanne M Jordan
Journal:  J Rheumatol       Date:  2011-02-01       Impact factor: 4.666

Review 4.  Productivity Losses and Costs in the Less-Common Systemic Autoimmune Rheumatic Diseases.

Authors:  Natalie McCormick; Carlo A Marra; J Antonio Aviña-Zubieta
Journal:  Curr Rheumatol Rep       Date:  2017-10-30       Impact factor: 4.592

5.  Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability.

Authors:  A M Bertoli; M Fernández; G S Alarcón; L M Vilá; J D Reveille
Journal:  Ann Rheum Dis       Date:  2006-06-30       Impact factor: 19.103

6.  Impact of obesity on functioning among women with systemic lupus erythematosus.

Authors:  Patricia Katz; Jinoos Yazdany; Laura Julian; Laura Trupin; Mary Margaretten; Edward Yelin; Lindsey A Criswell
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-10       Impact factor: 4.794

7.  Health-related quality of life for patients with vasculitis and their spouses.

Authors:  Delesha M Carpenter; Carolyn T Thorpe; Megan Lewis; Robert F Devellis; Susan L Hogan
Journal:  Arthritis Rheum       Date:  2009-02-15

8.  Impact of early systemic lupus erythematosus on work disability-results from the Finnish nationwide register 2000-2007.

Authors:  Pia Elfving; Kari Puolakka; Vappu Rantalaiho; Hannu Kautiainen; Lauri J Virta; Oili Kaipiainen-Seppänen
Journal:  Clin Rheumatol       Date:  2018-03-14       Impact factor: 2.980

9.  Disability in valued life activities among individuals with systemic lupus erythematosus.

Authors:  Patricia Katz; Anne Morris; Laura Trupin; Jinoos Yazdany; Edward Yelin
Journal:  Arthritis Rheum       Date:  2008-04-15

10.  Understanding systemic lupus erythematosus patients' desired outcomes and their perceptions of the risks and benefits of using corticosteroids.

Authors:  X Ng; S dosReis; R Beardsley; L Magder; C D Mullins; M Petri
Journal:  Lupus       Date:  2017-08-31       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.